Search research articles
Contact Us
Filters
Showing results (31-40 of 114) with videos related to
Page
of 12
Sort By:
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
November 8, 2025
Long-term survival of patients who received atezolizumab plus bevacizumab treatment for advanced hepatocellular carcinoma
Ching-Tso Chen, Yin-Hsun Feng, Chia-Jui Yen, et al.
The Lancet Regional Health. Western Pacific
|
September 30, 2021
Impact of expanded strong opioid availability on opioid prescription patterns in patients with cancer: A population-wide cohort study in Taiwan
Tsung-Che Wu, Chih-Hung Hsu, Wei-Zen Sun, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
May 26, 2010
Characteristics and risk factors of oxaliplatin-related hypersensitivity reactions
Yu-Yun Shao, Fu-Chang Hu, Jin-Tung Liang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 16, 2015
High Serum Transforming Growth Factor-β1 Levels Predict Outcome in Hepatocellular Carcinoma Patients Treated with Sorafenib
Tzu-Hsuan Lin, Yu-Yun Shao, Soa-Yu Chan, et al.
Cancer Letters
|
July 20, 2016
Inhibition of the Wnt/β-catenin signaling pathway improves the anti-tumor effects of sorafenib against hepatocellular carcinoma
Hsiao-Hui Lin, Wen-Chi Feng, Li-Chun Lu, et al.
International Journal of Hepatology
|
May 22, 2013
Modern prospection for hepatic arterial infusion chemotherapy in malignancies with liver metastases
Yi-Hsin Liang, Yu-Yun Shao, Jia-Yi Chen, et al.
Biology Direct
|
April 11, 2025
Downregulation of PD-L1 expression by Wnt pathway inhibition to enhance PD-1 blockade efficacy in hepatocellular carcinoma
Yu-Yun Shao, Han-Yu Wang, Hung-Wei Hsu, et al.
Journal of the Chinese Medical Association : JCMA
|
January 12, 2021
Potential of circulating immune cells as biomarkers of nivolumab treatment efficacy for advanced hepatocellular carcinoma
Yi-Ping Hung, Yu-Yun Shao, Jan-Mou Lee, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
July 12, 2020
Total skeletal, psoas and rectus abdominis muscle mass as prognostic factors for patients with advanced hepatocellular carcinoma
Chih-Horng Wu, Po-Chin Liang, Chih-Hung Hsu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
December 18, 2020
The unique characteristic in peripheral immune cells in patients with advanced hepatocellular carcinoma
Yi-Ping Hung, Yu-Yun Shao, Chiun Hsu, et al.
Page
of 12
Search research articles
Search
Showing results (31-40 of 114) with videos related to
Sort By:
Page
of 12
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
November 8, 2025
Long-term survival of patients who received atezolizumab plus bevacizumab treatment for advanced hepatocellular carcinoma
Ching-Tso Chen, Yin-Hsun Feng, Chia-Jui Yen, et al.
The Lancet Regional Health. Western Pacific
|
September 30, 2021
Impact of expanded strong opioid availability on opioid prescription patterns in patients with cancer: A population-wide cohort study in Taiwan
Tsung-Che Wu, Chih-Hung Hsu, Wei-Zen Sun, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
May 26, 2010
Characteristics and risk factors of oxaliplatin-related hypersensitivity reactions
Yu-Yun Shao, Fu-Chang Hu, Jin-Tung Liang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 16, 2015
High Serum Transforming Growth Factor-β1 Levels Predict Outcome in Hepatocellular Carcinoma Patients Treated with Sorafenib
Tzu-Hsuan Lin, Yu-Yun Shao, Soa-Yu Chan, et al.
Cancer Letters
|
July 20, 2016
Inhibition of the Wnt/β-catenin signaling pathway improves the anti-tumor effects of sorafenib against hepatocellular carcinoma
Hsiao-Hui Lin, Wen-Chi Feng, Li-Chun Lu, et al.
International Journal of Hepatology
|
May 22, 2013
Modern prospection for hepatic arterial infusion chemotherapy in malignancies with liver metastases
Yi-Hsin Liang, Yu-Yun Shao, Jia-Yi Chen, et al.
Biology Direct
|
April 11, 2025
Downregulation of PD-L1 expression by Wnt pathway inhibition to enhance PD-1 blockade efficacy in hepatocellular carcinoma
Yu-Yun Shao, Han-Yu Wang, Hung-Wei Hsu, et al.
Journal of the Chinese Medical Association : JCMA
|
January 12, 2021
Potential of circulating immune cells as biomarkers of nivolumab treatment efficacy for advanced hepatocellular carcinoma
Yi-Ping Hung, Yu-Yun Shao, Jan-Mou Lee, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
July 12, 2020
Total skeletal, psoas and rectus abdominis muscle mass as prognostic factors for patients with advanced hepatocellular carcinoma
Chih-Horng Wu, Po-Chin Liang, Chih-Hung Hsu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
December 18, 2020
The unique characteristic in peripheral immune cells in patients with advanced hepatocellular carcinoma
Yi-Ping Hung, Yu-Yun Shao, Chiun Hsu, et al.
Page
of 12